Business UpdateJun 9, 2026, 08:06 AM
Alps Subsidiary MyGenome Gets WGS Accreditation Under ISO 15189:2022
AI Summary
Alps Group Inc. announced that its subsidiary, MyGenome Sdn. Bhd., received MS ISO 15189:2022 accreditation for its Whole Genome Sequencing (WGS). This internationally recognized clinical standard validates MyGenome's genomic data for accuracy, reproducibility, and reliability in clinical use and research. The accreditation expands Alps' addressable market to include government-linked healthcare programs and institutional clients across Southeast Asia, positioning MyGenome among a select group of genomics laboratories in the region.
Key Highlights
- Alps' subsidiary, MyGenome Sdn. Bhd., received MS ISO 15189:2022 accreditation for Whole Genome Sequencing (WGS).
- MS ISO 15189:2022 is an internationally recognized clinical standard for quality and competence in medical laboratories.
- The accreditation confirms MyGenome's genomic data meets accuracy, reproducibility, and reliability benchmarks for clinical use.
- This positions MyGenome among a select group of genomics laboratories in Southeast Asia operating WGS under this standard.
- The milestone broadens Alps' addressable market to include government-linked healthcare programs and institutional clients.
Price Impact
More from ALPS